ATORVASTATIN REDUCES ENA-78 CHEMOKINE CONCENTRATIONS INDEPENDENT OF LDL-C CHANGES IN A CARDIOVASCULAR DISEASE FREE POPULATION.

被引：0
|
作者：
Welder, G. J. [1 ]
Schofield, R. S. [2 ]
Zineh, I. [1 ]
机构：
[1] Univ Florida, Dept Pharm Practice, Gainesville, FL USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 13 条
  • [11] Type 2 Diabetes and the Presence of PAD vs. CAD Are Strong and Independent Predictors of LDL-C Target Achievement in Statin-Treated Patients with Established Cardiovascular Disease
    Plattner, Thomas
    Vonbank, Alexander
    Mader, Arthur
    Sprenger, Lukas
    Maechler, Maximilian
    Larcher, Barbara
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2023, 72
  • [12] Non-HDL-C and LDL-C/HDL-C are associated with self-reported cardiovascular disease in a rural West African population: Analysis of an array of lipid metrics in an AWI-Gen sub-study
    Agongo, Godfred
    Raal, Frederick
    Nonterah, Engelbert A.
    Debpuur, Cornelius
    Oduro, Abraham R.
    Ramsay, Michele
    Crowther, Nigel J.
    PLOS ONE, 2022, 17 (12):
  • [13] Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States
    Baum, Seth J.
    Rane, Pallavi B.
    Nunna, Sasikiran
    Habib, Mohdhar
    Philip, Kiran
    Sun, Kainan
    Wang, Xin
    Wade, Rolin L.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 6
12